Compare RGEN & HBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | HBM |
|---|---|---|
| Founded | 1981 | 1927 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 6.7B |
| IPO Year | N/A | N/A |
| Metric | RGEN | HBM |
|---|---|---|
| Price | $163.80 | $18.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | ★ $170.90 | $19.50 |
| AVG Volume (30 Days) | 778.3K | ★ 4.9M |
| Earning Date | 10-28-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 0.08% |
| EPS Growth | N/A | ★ 396.15 |
| EPS | 0.03 | ★ 1.16 |
| Revenue | $707,890,000.00 | ★ $2,063,000,000.00 |
| Revenue This Year | $17.84 | $10.73 |
| Revenue Next Year | $12.57 | $12.47 |
| P/E Ratio | $6,437.16 | ★ $15.84 |
| Revenue Growth | ★ 11.74 | 1.20 |
| 52 Week Low | $102.97 | $5.95 |
| 52 Week High | $182.52 | $18.44 |
| Indicator | RGEN | HBM |
|---|---|---|
| Relative Strength Index (RSI) | 54.87 | 66.48 |
| Support Level | $160.11 | $16.90 |
| Resistance Level | $170.40 | $18.00 |
| Average True Range (ATR) | 5.38 | 0.69 |
| MACD | -0.85 | 0.19 |
| Stochastic Oscillator | 44.68 | 94.41 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
Hudbay Minerals Inc is a Canadian mining company with its operations, property developments, and exploration activities across the United States. The mines that Hudbay operates are located in Manitoba, Canada, Arizona, United States; and Peru. The company is principally focused on the discovery, production, and marketing of base and precious metals. Hudbay produces copper concentrate, which contains copper, gold, and silver, as well as zinc metal. More than half the company's revenue is attributable to the copper business. The company sells copper concentrates to smelters across Asia, America, and Europe, and sells Zinc metal, another source of revenue, to industrial customers across North America.